S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q2 2021

RA Capital Management

Period: Q2 2021 Β· Filed: 2021-08-16
View on SEC EDGAR β†—
AUM
$6.23B
Total portfolio value
Positions
92
Reported securities
Top Holding
ASND
14.4% $895.4M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-08-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$895.4M14.37%$131.55$274.50+108.7%
14.4%
NVAXNOVAVAX INC$543.5M8.72%$212.31$9.74-95.4%
8.7%
FMTXFORMA THERAPEUTICS HLDGS INC$224.3M3.60%β€”β€”
3.6%
JANXJANUX THERAPEUTICS INC$216.3M3.47%$24.95$15.54-37.7%
3.5%
VORXXXXVOR BIOPHARMA INC$207.4M3.33%β€”β€”
3.3%
AVTEAEROVATE THERAPEUTICS INC$188.7M3.03%β€”β€”
3.0%
NKTXNKARTA INC$177.6M2.85%$31.69$3.22-89.8%
2.9%
MGNXMACROGENICS INC$159.7M2.56%$26.86$4.71-82.5%
2.6%
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$136.5M2.19%β€”β€”
2.2%
TGTXTG THERAPEUTICS INC$129.7M2.08%$38.79$53.31+37.4%
2.1%
IMGNIMMUNOGEN INC$121.4M1.95%β€”β€”
1.9%
AVIRATEA PHARMACEUTICALS INC$115.3M1.85%$21.48$4.98-76.8%
1.9%
ITOSITEOS THERAPEUTICS INC$113.3M1.82%β€”β€”
1.8%
DAWNDAY ONE BIOPHARMACEUTICALS I$113.1M1.81%β€”β€”
1.8%
AXSMAXSOME THERAPEUTICS INC$111.7M1.79%$67.46$244.31+262.2%
1.8%
PHATPHATHOM PHARMACEUTICALS INC$105.4M1.69%$33.85$11.20-66.9%
1.7%
TILINSTIL BIO INC$94.1M1.51%$386.40$7.73-98.0%
1.5%
RCKTROCKET PHARMACEUTICALS INC COM$93.3M1.50%$44.29$3.84-91.3%
1.5%
ETNB89BIO INC$92.9M1.49%β€”β€”
1.5%
ZGNXZOGENIX INC$91.3M1.47%β€”β€”
1.5%
PCVXVAXCYTE INC$87.0M1.40%$22.51$58.39+159.4%
1.4%
KNTEKINNATE BIOPHARMA INC$83.7M1.34%β€”β€”
1.3%
GRPHGRAPHITE BIO INC$82.9M1.33%β€”β€”
1.3%
TVTXTRAVERE THERAPEUTICS INC$81.9M1.31%$14.59$56.92+290.1%
1.3%
HOWLWEREWOLF THERAPEUTICS INC$74.8M1.20%$17.44$0.34-98.0%
1.2%
RYTMRHYTHM PHARMACEUTICALS INC$71.1M1.14%$19.58$114.17+483.1%
1.1%
CYTTCYTEIR THERAPEUTICS INC$69.5M1.12%β€”β€”
1.1%
GHRSGH RESEARCH PLC$64.7M1.04%$21.73$27.01+24.3%
1.0%
OLMAOLEMA PHARMACEUTICALS INC$60.2M0.97%$27.98$12.64-54.8%
1.0%
DYNDYNE THERAPEUTICS INC$59.0M0.95%$21.04$23.07+9.7%
0.9%

Quarter-on-Quarter Activity

Q2 2021 vs. Q1 2021

New Positions (8)

TickerIssuerNotionalSince Filing
JANXJANUX THERAPEUTICS INC$216.3M-37.7%
AVTEAEROVATE THERAPEUTICS INC$188.7M
DAWNDAY ONE BIOPHARMACEUTICALS I$113.1M
GRPHGRAPHITE BIO INC$82.9M
HOWLWEREWOLF THERAPEUTICS INC$74.8M-98.0%
CYTTCYTEIR THERAPEUTICS INC$69.5M
GHRSGH RESEARCH PLC$64.7M+24.3%
VERVVERVE THERAPEUTICS INC$53.0M

Exited Positions (8)

TickerIssuerNotional
ADVMADVERUM BIOTECHNOLOGIES INC$92.3M
IGMSIGM BIOSCIENCES INC$75.4M
CNSTCONSTELLATION PHARMCETICLS INC$52.4M
STROSUTRO BIOPHARMA INC$48.2M
RLAYRELAY THERAPEUTICS INC$34.6M
SNDXSYNDAX PHARMACEUTICALS INC$22.9M
PRQRPROQR THERAPEUTICS N V$14.0M
ARYAARYA SCIENCES ACQUISITION CO$13.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
KALVKALVISTA PHARMACEUTICALS INC$37.3M+451.5%
ACHLACHILLES THERAPEUTICS PLC$26.1M+261.1%
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$81.2M+133.7%
MCRBSERES THERAPEUTICS INC$-74.2M+38.2%
MGNXMACROGENICS INC$2.5M+20.5%-82.5%
ASNDASCENDIS PHARMA A/S$69.0M+6.1%+108.7%
ETNB89BIO INC$-19.3M+4.8%
ITOSITEOS THERAPEUTICS INC$-37.7M+0.0%

Trimmed (3)

TickerIssuerNotionalShares Ξ”Since Filing
TGTXTG THERAPEUTICS INC$-93.8M-27.9%+37.4%
NVAXNOVAVAX INC$-0.8M-14.7%-95.4%
CCXICHEMOCENTRYX INC$-135.4M-1.7%
← Back to Hedge Funds